Effects of Zika Virus Strain and Aedes Mosquito Species on Vector Competence - Volume 23, Number 7—July 2017 - Emerging Infectious Disease journal - CDC

Effects of Zika Virus Strain and Aedes Mosquito Species on Vector Competence - Volume 23, Number 7—July 2017 - Emerging Infectious Disease journal - CDC

Volume 23, Number 7—July 2017

Research

Effects of Zika Virus Strain and Aedes Mosquito Species on Vector Competence

On This Page

• Methods
• Results
• Discussion
• Cite This Article

Figures

• Figure 1
• Figure 2
• Figure 3
• Figure 4

Tables

• Table 1
• Table 2

Downloads

• PDF[1.12 MB - 8 pgs]
• RIS[TXT - 2 KB]

Altmetric

Alexander T. Ciota , Sean M. Bialosuknia, Steven D. Zink, Matthew Brecher, Dylan J. Ehrbar, Madeline N. Morrissette, and Laura D. Kramer

Author affiliations: New York State Department of Health, Slingerlands, New York, USA (A.T. Ciota, S.M. Bialosuknia, S.D. Zink, M. Brecher, D.J. Ehrbar, M.N. Morrissette, L.D. Kramer); State University of New York at Albany School of Public Health, Albany, New York, USA (A.T. Ciota, L.D. Kramer)

Cite This Article

Abstract

In the Western Hemisphere, Zika virus is thought to be transmitted primarily by Aedes aegypti mosquitoes. To determine the extent to which Ae. albopictus mosquitoes from the United States are capable of transmitting Zika virus and the influence of virus dose, virus strain, and mosquito species on vector competence, we evaluated multiple doses of representative Zika virus strains in Ae. aegypti and Ae. albopictus mosquitoes. Virus preparation (fresh vs. frozen) significantly affected virus infectivity in mosquitoes. We calculated 50% infectious doses to be 6.1–7.5 log10 PFU/mL; minimum infective dose was 4.2 log10 PFU/mL. Ae. albopictus mosquitoes were more susceptible to infection than Ae. aegypti mosquitoes, but transmission efficiency was higher for Ae. aegypti mosquitoes, indicating a transmission barrier in Ae. albopictus mosquitoes. Results suggest that, although Zika virus transmission is relatively inefficient overall and dependent on virus strain and mosquito species, Ae. albopictus mosquitoes could become major vectors in the Americas.

Zika virus (family Flaviviridae, genus Flavivirus) is the latest in a series of arboviruses to successfully invade the Americas; cases locally acquired in the Western Hemisphere were first identified in Brazil in May 2015 (1), and invasion subsequently expanded throughout Latin America and into the United States. To date, >460,000 suspected cases of autochthonous transmission have occurred in at least 45 Western countries (http://www.paho.org). Zika virus was first isolated in Uganda in 1947 (2) but was not implicated in a major epidemic until an explosive outbreak occurred on the island of Yap in Micronesia in 2007 (3). Subsequent outbreaks occurred in Cambodia in 2010, French Polynesia in 2013, and surrounding South Pacific islands in 2014 (4). Phylogenetic studies have suggested that the South Pacific islands are probably the source of the current outbreak in the Americas (5).

Although Zika virus infection had generally been thought to be asymptomatic or to result in a mild febrile illness (6), the 2013 outbreak marked the first time the virus was implicated as a causative agent of Guillain-Barré syndrome (7). It has also been confirmed that Zika virus can have teratogenic effects (8), causing a spectrum of neurologic problems, referred to as Zika congenital syndrome, in developing fetuses (9), particularly in women infected during their first trimester of pregnancy (10). Although the primary route of transmission is through blood feeding by an infected mosquito, efficient sexual transmission (11) and long-term persistence in male reproductive tissues and fluids have been well documented (12).

Epidemiologic and laboratory studies have implicated various Aedes spp. mosquitoes as Zika virus vectors (3,13–16). In the Americas, Ae. aegypti mosquitoes are the primary vector for Zika virus, as they are for dengue and chikungunya viruses (17). Ae. albopictus mosquitoes potentially act as a secondary or supplemental vector (18). In the laboratory, mosquitoes of both species have been shown to be efficient vectors (14,18–20). However, few Zika virus isolates have been obtained from mosquitoes in the Americas and few experiments have assessed competence with currently circulating strains and representative mosquito populations. In addition, because previous experimental studies generally used individual blood meal doses with virus titers rarely achieved in nature, the relationship between viremia levels and vector competence is largely uncharacterized, making determination of the duration and likelihood of host transmissibility difficult.

We conducted comparative studies of recent Zika virus isolates from the Americas and an isolate from the 2010 outbreak in Cambodia (21). Genetic differences identified among these strains translated to modest variability in replicative kinetics in vitro in mosquito (C6/36) and mammalian (Vero) cells. In addition, we characterized the dose response for vector competence in Ae. aegypti mosquitoes and a recently colonized Ae. albopictus mosquito population from New York, USA.

Methods

Viruses

The New York State Department of Health (NYSDOH) Arbovirus Laboratory isolated Zika virus HND (2016–19563, GenBank accession no. KX906952) from serum from a patient who had traveled to Honduras in early 2016. Amplification was obtained by inoculating 100 μL of serum into shell vials (ViroMed Laboratories, Burlington, NC, USA) confluent with Vero cells (ATCC, Manassas, VA, USA), followed by centrifugation at 700 × g for 40 min at 37°C and an additional 4 days of growth (22). Zika virus CAM (strain FSS130325, GenBank accession no. JN860885; kindly provided by C. Pager, State University of New York at Albany, NY, USA) was originally isolated in 2010 from human serum in Cambodia and passaged 3 times on Vero cell culture and 1 time on C6/36 cell culture. Zika virus PR (kindly provided by the Centers for Disease Control and Prevention, Fort Collins, CO, USA; strain PRCABC59, GenBank accession no. KU5012 15), used for preliminary experiments, was initially obtained from serum of a patient who had traveled to Puerto Rico in 2015 and was passaged 3 times on Vero cell culture and 1 time on C6/36 cell culture. Nucleotide and amino acid sequence alignments were created with Zika virus coding regions by using the MegAlign module of the DNAStar software package (http://www.dnastar.com).

In Vitro Growth Kinetics

We inoculated confluent monolayers of Vero and C6/36 cells with Zika virus strains in duplicate at a multiplicity of infection of 0.01 PFU/cell. After a 1-hour absorption period at 37°C (Vero) or 28°C (C6/36), the inoculum was removed and cells were washed twice with appropriate maintenance media. Cultures were maintained in 6-well plates with 3 mL of maintenance media (Eagle minimum essential medium with 2% fetal bovine serum) and incubated at 37°C (Vero) or 28°C (C6/36). Samples of 100 μL supernatant were harvested at days 1–4 (Vero) or 1–7 (C6/36) after infection, diluted 1:10 in media containing 20% fetal bovine serum, and stored at −80°C. Titrations were performed in duplicate, by plaque assay on Vero cells (23); mean titers for each time point were calculated and compared by t-test. Growth kinetics were compared by using repeated measured analysis of variance (ANOVA) and Tukey post hoc tests (GraphPad Prism version 5.0; GraphPad Software, La Jolla, CA, USA).

Experimental Infections and Mosquito Competence

Ae. albopictus mosquitoes (kindly provided by Illia Rochlin, Suffolk County Health Department, Yaphank, NY, USA) were originally collected in Suffolk County in 2014 and subsequently colonized in the NYSDOH Arbovirus Laboratory. F5–F7 female mosquitoes from New York were used for experimental feedings. Ae. aegypti mosquitoes used for preliminary experiments were collected by C. Mangudo in Salta, Argentina, in 2014 and initially colonized by V. Micieli and L.D. Kramer at the Centro de Estudios de Parasitología y Vectores (La Plata, Argentina) before being shipped to the NYSDOH Arbovirus Laboratory for maintenance. F4–F5 females from Argentina were used for experimental feedings. Ae. aegypti mosquitoes (kindly provided by G.D. Ebel, Colorado State University, Fort Collins, CO, USA) were originally collected in Poza Rica, Mexico. F7–F8 females from Mexico were used for experimental feedings. For preliminary blood feeding experiments, Ae. aegypti mosquitoes from Argentina were fed Zika virus PR stock virus diluted 1:1, 1:5, or 1:20 in defibrinated sheep blood (Colorado Serum Co., Denver, CO, USA) with 2.5% sucrose. For feedings with freshly propagated virus, supernatant from infected C6/36 cultures was harvested at 96 h after infection (multiplicity of infection ≈1.0) and diluted 1:1 with blood-sucrose mixture without freezing. Female mosquitoes, 4–7 days of age, were deprived of sucrose for 18–24 h and offered blood meal mixtures by use of a Hemotek membrane feeding system (Discovery Workshops, Acrington, UK) with a porcine sausage casing membrane. For all subsequent experiments assessing dose-dependent vector competence, similarly prepared fresh C6/36 cultures of Zika virus HND and Zika virus CAM were used to feed Ae. aegypti mosquitoes from Mexico and Ae. albopictus mosquitoes from New York. In addition to undiluted supernatant, 1:20, 1:400, and 1:8,000 dilutions were made in C6/36 maintenance media before being mixed with blood.

For all blood feeding experiments, mosquitoes were sedated with CO2 after 1 h of feeding, and fully engorged mosquitoes were transferred to 0.6-L cartons and maintained at 27°C for experimental testing. Infection, dissemination, and transmission rates were determined as previously described (24) on day 14 or 21 after feeding. After the mosquitoes were sedated, the legs were removed from 12–30 mosquitoes and placed in 1 mL mosquito diluent (20% heat-inactivated fetal bovine serum in Dulbecco phosphate-buffered saline plus 50 μg/mL penicillin/streptomycin, 50 μg/mL gentamicin, and 2 μg/mL Fungizone [Sigma Aldrich, St. Louis, MO, USA]). For 30 minutes, mosquitoes were allowed to expectorate into capillary tubes containing ≈20 μL fetal bovine serum plus 50% sucrose (1:1), at which time the mixture was ejected into 250 μL mosquito diluent. Mosquito bodies were then placed in individual tubes with mosquito diluent. All samples were held at −80°C until tested. To test for infection, dissemination, and transmission, we processed and screened bodies, legs, and salivary secretions, respectively, by Zika virus–specific quantitative reverse transcription PCR (25). Zika virus body titers were calculated from standard curves based on infectious particle standards created from matched virus stocks. Data were analyzed by using GraphPad Prism version 4.0. Rates were compared by using Fisher exact tests, and dose dependence was evaluated and compared by using linear regression analyses.

Results

In Vitro Characterization

Figure 1. Growth kinetics of Zika virus in A) mosquito (C6/36) and B) mammalian (Vero) cells. Cells were infected in duplicate with Zika virus strain CAM, PR, or HND, at a multiplicity of...

Sequencing analysis of these strains revealed 1.7% divergence and 16 aa differences distributed throughout the genome (Table 1). These differences include 8 aa in capsid; premembrane; envelope; and nonstructural 1, 3, and 5 genes, which differ from Zika virus CAM and are shared among the 2 isolates from the Americas. Peak virus titers were ≈3-fold higher on mosquito cells than on mammalian cells. Although in vitro kinetics were similar among strains (Figure 1), Zika virus CAM replicated to modestly higher titers (mean difference 3.0-fold by repeated measures ANOVA; p<0.05 by Tukey multiple comparison test) relative to Zika virus PR and HND and a significantly higher peak titer (mean 5.3-fold; p<0.05 by t-test). Zika virus HND was also modestly attenuated in mammalian cell culture, replicating to titers 2–3.3-fold lower than the titers achieved by Zika virus PR and Zika virus CAM, respectively (repeated measures ANOVA, by Tukey multiple comparison test). Peak titer for Zika virus CAM was statistically higher than that for Zika virus HND (p = 0.04 by t-test), yet Zika virus PR replicated to an intermediate value and was statistically equivalent to both Zika virus HND and CAM.

Infectivity and Vector Competence

Figure 2. Relationship between dose, infectivity, and preparation of Zika virus for Aedes aegypti mosquitoes. Quantitative reverse transcription PCR was used to test 12–25 processed Ae. aegypti mosquitoes for Zika virus 14 days...

Initial experiments that used previously amplified Zika virus PR stock frozen at −80°C failed to achieve high levels of infection in Ae. aegypti mosquitoes. No infection was identified at 14 days after feeding for mosquitoes fed 6.0 log10 PFU/mL, and only 3 (10%) of 30 mosquitoes were Zika virus positive when the dose was increased to 7.4 log10 PFU/mL (Figure 2). In an effort to achieve higher infectivity, we freshly harvested supernatant from mosquito cells after virus propagation and immediately used it for blood meal preparation. Blood meal titers for this experiment were high, 9.1 log10 PFU/mL, as were rates of infection and dissemination. At day 14 after feeding, 24 (96%) of 25 mosquitoes were Zika virus positive. Of the 24 positive mosquitoes, 22 (91.6%) had disseminated infections and 13 (54.2%) had Zika virus–positive saliva. To clarify the extent to which differences in infectivity were the result of virus titer or preparation (freshly propagated vs. frozen virus stocks), we fed a subset of mosquitoes the same blood meal (titer 9.1 log10 PFU/mL) after freezing at −80°C for 2 weeks. Although feeding rates were poor and survival was low for this cohort (n = 12), only 2 of the mosquitoes surviving to day 14 after feeding were Zika virus positive, which equated to a significantly lower infection rate than that obtained with freshly propagated virus (p<0.001 by Fisher exact test; Figure 2). All subsequent experiments were therefore completed with C6/36-derived Zika virus–positive supernatant before freezing.

Figure 3. Viral load of Zika virus in Aedes mosquito bodies at day 21 after infection. Zika viral load (PFU equivalents) was determined in whole mosquitoes by using Zika virus–specific quantitative reverse transcription...

After isolation, Zika virus HND was used as the representative Western Hemisphere strain and compared with Zika virus CAM for all experiments assessing the relationships between dose, vector competence, virus strain, and mosquito species. To maximize transmission potential, we waited until day 21 after mosquito feeding to conduct these studies. For Ae. aegypti mosquito feedings, the highest doses achieved for Zika virus HND and CAM were 8.9 and 8.7 log10 PFU/mL, respectively. Similar titers of 8.9 (Zika virus HND) and 8.6 (Zika virus CAM) log10 PFU/mL were used for Ae. albopictus feedings (Table 2). For Zika virus HND, significantly higher viral loads were measured in Ae. aegypti relative to Ae. albopictus mosquitoes at both the highest dose and the 1:20 dilution (≈7.5 log10 PFU/mL; Figure 3; p<0.01 by t-test). Although differences were also measured at the lower doses, deviation is higher and statistical power is constrained by the smaller sample sizes. Viral loads among mosquitoes of each species were similar for Zika virus CAM, yet significantly higher than Zika virus HND in Ae. albopictus mosquitoes (Figure 3; p<0.001 by t-test), indicating an influence of mosquito species and of virus strain on Zika virus replication.

Infection rates for high-dose feedings were 80%–100% (Table 2). Susceptibility, particularly for Zika virus HND, was generally higher among Ae. albopictus mosquitoes. This difference was highly significant for the Zika virus HND 1:20 dilution (≈7.5 log10 PFU/mL), for which 93.3% of Ae. albopictus mosquitoes were infected compared with 46.7% of Ae. aegypti mosquitoes (p<0.001 by Fisher exact test). Although the higher infection rate measured in Ae. albopictus mosquitoes was not significant at the 1:400 dilution (33.3% vs. 16.7%; p = 0.233 by Fisher exact test), it is notable that the input titer was ≈5-fold lower for the Ae. albopictus mosquito feeding (6.6 vs. 5.9 log10 PFU/mL), consistent with the increased infectiousness of Zika virus HND in this species.

Figure 4. Relationship between dose and competence of Aedes aegypti and Ae. albopictus mosquitoes for Zika virus HND and CAM. Graphs show proportion of blood-engorged mosquitoes infected, with disseminated infections, and transmitting. Lines...

To measure and compare dose dependence and competence among species and strains, we completed linear regression analyses of each individual feeding and used best-fit lines to calculate doses at which 50% of mosquitoes were infected, had disseminated infections, and were capable of transmission (ID50, DD50, TD50,respectively; Figure 4). Although the relationship between dose and infection (as measured by slope) was similar among strains and species, infectiousness was higher in Ae. albopictus relative to Ae. aegypti mosquitoes for both strains. Infectiousness was determined both by statistical comparison of Y-intercepts by linear regression analyses (p<0.05) and comparisons of calculated ID50s. The ID50 of Zika virus HND was found to be greater than a log lower in Ae. albopictus compared with Ae. aegypti mosquitoes (6.1 vs. 7.5 log10 PFU/mL) and ≈5-fold lower for Zika virus CAM (6.6 vs. 7.3 log10 PFU/mL; Figure 4).

The increased infectivity of Ae. albopictus mosquitoes did not translate to increased rates of dissemination and transmission (Table 2; Figure 4) and is consistent with the fact that similar (Zika virus CAM) or lower (Zika virus HND) viral loads were measured in mosquitoes of this species (Figure 3). Dissemination rates for infected individuals were generally statistically equivalent among strains and species. Significant differences were achieved only when compared with the Ae. albopictus mosquito 1:20 Zika virus CAM feeding, yet the input titer for this feeding was ≈1 log10 lower than that for the other 1:20 feedings, which probably contributed to this difference. The linear regression analysis, for which the exact dose is considered, demonstrates again that the relationship of dissemination rate and dose is similar among virus strain and mosquito species (Figure 4). Although DD50 values for both strains were lower in Ae. albopictus mosquitoes, differences were significant only for Zika virus HND and can be wholly explained by differences in infectivity.

Transmission rates for Ae. aegypti mosquitoes were consistently higher, particularly for Zika virus HND (Table 2). Although no transmission occurred in mosquitoes of either species at the lowest dose, an average of 45% more Zika virus HND–infected Ae. aegypti than Ae. albopictus mosquitoes transmitted virus. These differences were highly significant at the undiluted and 1:20 doses (≈8.8 and 7.5 log10 PFU/mL; p<0.001 by Fisher exact test; Table 2). Although transmission of Zika virus CAM was also higher among Ae. aegypti mosquitoes, differences were smaller and only significant at the 1:20 dose (p<0.001 by Fisher exact test; Table 2). It is notable that the only instance for which transmission was measured at the lowest dose (1:8,000, 4.3 log10PFU/mL) was with Zika virus CAM in Ae. aegypti mosquitoes. Despite increased infection rates for Ae. albopictus mosquitoes, dose dependence for Zika virus HND transmission was significantly lower than that for Ae. aegypti mosquitoes (p = 0.035 by linear regression analysis; Figure 4), resulting in a TD50≈4 log10 higher for Ae. albopictus mosquitoes. Overall transmission efficiency was highly strain dependent for Ae. albopictus mosquitoes; the TD50 of Zika virus CAM was ≈3 log10 lower than that for Zika virus HND. Unlike slopes and intercepts for Zika virus HND, those for Zika virus CAM TD50 were similar among species (Figure 4).

Discussion

Reports of autochthonous Zika virus transmission in Florida demonstrate the capacity of Zika virus to continue to expand in the Americas (26), yet a comprehensive assessment of the current and future threat requires experimental assessment of the transmission potential of various mosquito populations and circulating strains. Our initial attempts to infect large numbers of Ae. aegypti mosquitoes by using previously frozen stocks of Zika virus were largely unsuccessful, even at unnaturally high doses (>9.0 log10 PFU/mL). Previous studies have noted differences in arbovirus infectivity and vector competence when use of artificial feeding was compared with feeding on experimentally infected hosts (27) or previously frozen to freshly propagated stocks (28–30). These studies almost exclusively identified significant differences in vector competence with lower titer blood meals, yet our results clearly demonstrate that freezing/thawing of Zika virus significantly impairs infectivity to mosquitoes at a range of doses. Although the mechanistic basis of this difference has not been adequately studied and plaque assays did not indicate a decline in Zika virus infectious particles on Vero cell culture after freeze/thaw, differences in competence may be attributed to structural perturbations of the virion that inhibit efficient particle binding in vivo (31). Future studies characterizing Zika virus structure and binding could help elucidate the unique sensitivity of this virus to the negative effects of freeze/thaw.

Although information about Zika virus kinetics and tropism in humans remains limited, current estimates of mean viremia range from 4.4 to 4.7 log10copies/mL, probably equating to <2.5 log10 PFU/mL (25,32). Symptomatic persons may at times have higher levels of viremia (32,33), and these estimates are probably low because sample acquisition generally occurs after symptom onset (well past peak viremia) and because titers may be higher in whole blood than in serum (34). Despite these caveats, current data still suggest that peak and mean levels for dengue and chikungunya viruses are substantially higher than those for Zika virus (32). Of course, transmission efficiency of host to vector is dependent on both host viremia and vector susceptibility. Calculations of ID50 for dengue and chikungunya viruses in Aedes spp. mosquitoes are variable but have generally been estimated to be <105 PFU/mL (35–37). We estimated Zika virus ID50 to be 6.1–7.5 log10 PFU/mL, with a low threshold for infection of 4.2 log10 PFU/mL. The recent success of Zika virus in the Western Hemisphere unequivocally demonstrates the capacity for widespread transmission, yet the combination of lower host viremia levels and mosquito susceptibility suggests that the intensity of vector-to-host transmission could be less efficient than has been observed with previous epidemics of dengue and chikungunya virus infection. It is feasible that efficient sexual transmission could supplement current levels of mosquito transmission (38) or that vertical transmission among particular mosquito populations could play a larger role than is documented for other flaviviruses (39–41). In addition, as demonstrated here and in previous studies (20), Zika virus vector competence can vary by virus strain and population, so particular vector/virus combinations may be more efficient at maintaining transmission. Highly variable vector competence that is specific for population and virus strain is well documented for other flaviviruses (42,43), and specific mosquito/virus genotype-by-genotype interactions have been well described in the Aedes mosquito/dengue virus system (42,44–46). Our analysis reveals 13 aa differences between the Zika virus 2010 CAM and 2016 HND strains and additional base changes that could be associated with phenotypically relevant changes to RNA structure. Although the CAM strain is ancestral to the America strains, it is notable that the 2 America strains used in this study (HND and PR) possess 8 aa differences. More comprehensive genetic studies demonstrate a range of mutations among strains currently circulating in the Western Hemisphere (5), all of which could feasibly translate to variability in virus fitness and vector competence.

We have demonstrated that US populations of Ae. albopictus mosquitoes exposed to a Zika virus strain currently circulating in the Americas are competent vectors that may be capable of maintaining virus transmission. Although these mosquitoes have been colonized for >1 year and may not be fully representative of current populations, this population was derived from a location (Suffolk County, NY) adjacent to New York City, which is among the largest centers for the movement of Zika virus–exposed travelers. Indeed, the highest number of confirmed travel-associated cases of Zika virus infection in the United States are reported from New York state (http://www.cdc.gov/zika/geo/united-states.html). The combination of the recent success of Ae. albopictus mosquitoes in the region (47) and the influx of viremic patients is probably what led to the first documented locally acquired case of dengue virus infection in the state (Suffolk County, 2013; http://diseasemaps.usgs.gov). Despite this potential vulnerability, transmission intensity is dependent on more than host and vector competence and it is the frequent and highly anthropophilic feeding of Ae. aegypti mosquitoes that often results in their relative success as vectors, even in the absence of high competence (48). In addition, the increased infectivity of Zika virus in Ae. albopictus mosquitoes does not translate to increased overall competence; transmission efficiency was significantly higher for Ae. aegypti mosquitoes. These data are consistent with a midgut escape barrier and, more significantly, with a salivary gland infection or transmission barrier. Although it is well documented that these barriers are capable of preventing transmission (49), increased infectivity in Ae. albopictus mosquitoes is notable because the increased infectivity we measured in Ae. albopictus mosquitoes translates to more opportunity for adaptive events that could increase fitness or competence over time. The potential epidemiologic consequences for adaptation to Ae. albopictus mosquitoes are well documented for chikungunya virus, for which primary and secondary epistatic mutations increased competence in mosquitoes of this species and facilitated the explosive outbreaks in the islands of the Indian Ocean and beyond (50). The combination of additional laboratory studies assessing the adaptive potential of Zika virus in various Ae. albopictus mosquito populations, together with continued genetic and phenotypic monitoring of circulating strains, will help elucidate the potential for similar adaptive events enabling increased transmission efficiency of Zika virus in the Americas.

Dr. Ciota is deputy director of The Arbovirus Laboratory at the Wadsworth Center, New York State Department of Health, and an assistant professor at the State University of New York at Albany School of Public Health, Department of Biomedical Sciences. His primary research interests are virus evolution and vector–virus interactions.

Acknowledgments

We thank members of the New York State Arbovirus Laboratory insectary staff for assistance with this project. We thank the Wadsworth Center tissue and media facility for supplying cells and media for these studies.

Construction of the Arbovirus Laboratory insectary facilities was partially funded by National Institutes of Health grant C06-RR-17715. These studies were partially funded by the Centers for Disease Control and Prevention Vector-borne Disease Regional Center of Excellence, CDC # CK17-005.

References

1. Zanluca C, Melo VC, Mosimann AL, Santos GI, Santos CN, Luz K. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz. 2015;110:569–72. DOIPubMed
2. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46:509–20. DOIPubMed
3. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360:2536–43. DOIPubMed
4. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 2014;20:O595–6. DOIPubMed
5. Wang L, Valderramos SG, Wu A, Ouyang S, Li C, Brasil P, et al. From mosquitos to humans: genetic evolution of Zika virus. Cell Host Microbe. 2016;19:561–5. DOIPubMed
6. Hamel R, Liégeois F, Wichit S, Pompon J, Diop F, Talignani L, et al. Zika virus: epidemiology, clinical features and host-virus interactions. Microbes Infect. 2016;18:441–9. DOIPubMed
7. Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:1531–9. DOIPubMed
8. Cugola FR, Fernandes IR, Russo FB, Freitas BC, Dias JL, Guimarães KP, et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature. 2016;534:267–71.PubMed
9. Adibi JJ, Marques ET Jr, Cartus A, Beigi RH. Teratogenic effects of the Zika virus and the role of the placenta. Lancet. 2016;387:1587–90. DOIPubMed
10. Johansson MA, Mier-y-Teran-Romero L, Reefhuis J, Gilboa SM, Hills SL. Zika and the risk of microcephaly. N Engl J Med. 2016;375:1–4. DOIPubMed
11. Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau VM. Potential sexual transmission of Zika virus. Emerg Infect Dis. 2015;21:359–61. DOIPubMed
12. Matheron S, d’Ortenzio E, Leparc-Goffart I, Hubert B, de Lamballerie X, Yazdanpanah Y. Long-lasting persistence of Zika virus in semen. Clin Infect Dis. 2016;63:1264.PubMed
13. Weger-Lucarelli J, Rückert C, Chotiwan N, Nguyen C, Garcia Luna SM, Fauver JR, et al. Vector competence of American mosquitoes for three strains of Zika virus. PLoS Negl Trop Dis. 2016;10:e0005101. DOIPubMed
14. Li MI, Wong PS, Ng LC, Tan CH. Oral susceptibility of Singapore Aedes (Stegomyia) aegypti (Linnaeus) to Zika virus. PLoS Negl Trop Dis. 2012;6:e1792. DOIPubMed
15. Grard G, Caron M, Mombo IM, Nkoghe D, Mboui Ondo S, Jiolle D, et al. Zika virus in Gabon (Central Africa)—2007: a new threat from Aedes albopictus? PLoS Negl Trop Dis. 2014;8:e2681. DOIPubMed
16. Ledermann JP, Guillaumot L, Yug L, Saweyog SC, Tided M, Machieng P, et al. Aedes hensilli as a potential vector of Chikungunya and Zika viruses.PLoS Negl Trop Dis. 2014;8:e3188. DOIPubMed
17. Guerbois M, Fernandez-Salas I, Azar SR, Danis-Lozano R, Alpuche-Aranda CM, Leal G, et al. Outbreak of Zika virus infection, Chiapas State, Mexico, 2015, and first confirmed transmission by Aedes aegypti mosquitoes in the Americas. J Infect Dis. 2016;214:1349–56. DOIPubMed
18. Wong PS, Li MZ, Chong CS, Ng LC, Tan CH. Aedes (Stegomyia) albopictus (Skuse): a potential vector of Zika virus in Singapore. PLoS Negl Trop Dis. 2013;7:e2348. DOIPubMed
19. Diagne CT, Diallo D, Faye O, Ba Y, Faye O, Gaye A, et al. Potential of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit Zika virus. BMC Infect Dis. 2015;15:492–7. DOIPubMed
20. Chouin-Carneiro T, Vega-Rua A, Vazeille M, Yebakima A, Girod R, Goindin D, et al. Differential susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika virus. PLoS Negl Trop Dis. 2016;10:e0004543. DOIPubMed
21. Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V, Huy R, et al. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis. 2012;6:e1477. DOIPubMed
22. Olsen MA, Shuck KM, Sambol AR, Flor SM, O’Brien J, Cabrera BJ. Isolation of seven respiratory viruses in shell vials: a practical and highly sensitive method. J Clin Microbiol. 1993;31:422–5.PubMed
23. Payne AF, Binduga-Gajewska I, Kauffman EB, Kramer LD. Quantitation of flaviviruses by fluorescent focus assay. J Virol Methods. 2006;134:183–9. DOIPubMed
24. Ebel GD, Rochlin I, Longacker J, Kramer LD. Culex restuans (Diptera: Culicidae) relative abundance and vector competence for West Nile Virus. J Med Entomol. 2005;42:838–43. DOIPubMed
25. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232–9. DOIPubMed
26. McCarthy M. Four in Florida are infected with Zika from local mosquitoes. BMJ. 2016;354:i4235. DOIPubMed
27. Hardy JL, Reeves WC. Experimental studies in infection in vectors. In: Reeves WC, editor. Epidemiology and control of mosquito-borne arboviruses in California. Sacramento (CA): California Mosquito and Vector Control Association; 1990. p. 145–253.
28. Miller BR. Increased yellow fever virus infection and dissemination rates in Aedes aegypti mosquitoes orally exposed to freshly grown virus. Trans R Soc Trop Med Hyg. 1987;81:1011–2. DOIPubMed
29. Turell MJ. Reduced Rift Valley fever virus infection rates in mosquitoes associated with pledget feedings. Am J Trop Med Hyg. 1988;39:597–602. DOIPubMed
30. Richards SL, Pesko K, Alto BW, Mores CN. Reduced infection in mosquitoes exposed to blood meals containing previously frozen flaviviruses. Virus Res. 2007;129:224–7. DOIPubMed
31. Hansen RK, Zhai S, Skepper JN, Johnston MD, Alpar HO, Slater NK. Mechanisms of inactivation of HSV-2 during storage in frozen and lyophilized forms. Biotechnol Prog. 2005;21:911–7. DOIPubMed
32. Waggoner JJ, Gresh L, Vargas MJ, Ballesteros G, Tellez Y, Soda KJ, et al. Viremia and clinical presentation in Nicaraguan patients infected with Zika virus, chikungunya virus, and dengue virus. Clin Infect Dis. 2016;63:1584–90. DOIPubMed
33. Brent C, Dunn A, Savage H, Faraji A, Rubin M, Risk I, et al. Preliminary findings from an investigation of Zika virus infection in a patient with no known risk factors—Utah, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:981–2. DOIPubMed
34. Mansuy JM, Mengelle C, Pasquier C, Chapuy-Regaud S, Delobel P, Martin-Blondel G, et al. Zika virus infection and prolonged viremia in whole-blood specimens. Emerg Infect Dis. 2017;23:863–5. DOIPubMed
35. Nguyet MN, Duong TH, Trung VT, Nguyen TH, Tran CNB, Long VT, et al. Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes. Proc Natl Acad Sci U S A. 2013;110:9072–7. DOIPubMed
36. Gubler DJ, Nalim S, Tan R, Saipan H, Sulianti Saroso J. Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti. Am J Trop Med Hyg. 1979;28:1045–52.PubMed
37. Armstrong PM, Rico-Hesse R. Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis. 2001;1:159–68. DOIPubMed
38. Coelho FC, Durovni B, Saraceni V, Lemos C, Codeco CT, Camargo S, et al. Higher incidence of Zika in adult women than adult men in Rio de Janeiro suggests a significant contribution of sexual transmission from men to women. Int J Infect Dis. 2016;51:128–32. DOIPubMed
39. Ciota AT, Bialosuknia SM, Ehrbar DJ, Kramer LD. Vertical transmission of Zika virus by Aedes aegypti and Ae. albopictus mosquitoes. Emerg Infect Dis. 2017;23:880–2. DOIPubMed
40. Rosen L, Shroyer DA, Tesh RB, Freier JE, Lien JC. Transovarial transmission of dengue viruses by mosquitoes: Aedes albopictus and Aedes aegypti.Am J Trop Med Hyg. 1983;32:1108–19.PubMed
41. Thangamani S, Huang J, Hart CE, Guzman H, Tesh RB. Vertical transmission of Zika virus in Aedes aegypti mosquitoes. Am J Trop Med Hyg. 2016;95:1169–73. DOIPubMed
42. Lambrechts L, Chevillon C, Albright RG, Thaisomboonsuk B, Richardson JH, Jarman RG, et al. Genetic specificity and potential for local adaptation between dengue viruses and mosquito vectors. BMC Evol Biol. 2009;9:160–70. DOIPubMed
43. Kilpatrick AM, Fonseca DM, Ebel GD, Reddy MR, Kramer LD. Spatial and temporal variation in vector competence of Culex pipiens and Cx. restuans mosquitoes for West Nile virus. Am J Trop Med Hyg. 2010;83:607–13. DOIPubMed
44. Lambrechts L, Quillery E, Noël V, Richardson JH, Jarman RG, Scott TW, et al. Specificity of resistance to dengue virus isolates is associated with genotypes of the mosquito antiviral gene Dicer-2. Proc Biol Sci. 2013;280:20122437. DOIPubMed
45. Pongsiri A, Ponlawat A, Thaisomboonsuk B, Jarman RG, Scott TW, Lambrechts L. Differential susceptibility of two field aedes aegypti populations to a low infectious dose of dengue virus. PLoS One. 2014;9:e92971. DOIPubMed
46. Zouache K, Fontaine A, Vega-Rua A, Mousson L, Thiberge JM, Lourenco-De-Oliveira R, et al. Three-way interactions between mosquito population, viral strain and temperature underlying chikungunya virus transmission potential. Proc Biol Sci. 2014;281:20141078. DOIPubMed
47. Rochlin I, Ninivaggi DV, Hutchinson ML, Farajollahi A. Climate change and range expansion of the Asian tiger mosquito (Aedes albopictus) in Northeastern USA: implications for public health practitioners. PLoS One. 2013;8:e60874. DOIPubMed
48. Miller BR, Monath TP, Tabachnick WJ, Ezike VI. Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol. 1989;40:396–9.PubMed
49. Kramer LD, Ebel GD. Dynamics of flavivirus infection in mosquitoes. Adv Virus Res. 2003;60:187–232. DOIPubMed
50. Tsetsarkin KA, McGee CE, Volk SM, Vanlandingham DL, Weaver SC, Higgs S. Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One. 2009;4:e6835. DOIPubMed

Figures

• Figure 1. Growth kinetics of Zika virus in A) mosquito (C6/36) and B) mammalian (Vero) cells. Cells were infected in duplicate with Zika virus strain CAM, PR, or HND, at a...
• Figure 2. Relationship between dose, infectivity, and preparation of Zika virus for Aedes aegypti mosquitoes. Quantitative reverse transcription PCR was used to test 12–25 processed Ae. aegypti mosquitoes for Zika virus...
• Figure 3. Viral load of Zika virus in Aedes mosquito bodies at day 21 after infection. Zika viral load (PFU equivalents) was determined in whole mosquitoes by using Zika virus–specific quantitative...
• Figure 4. Relationship between dose and competence of Aedes aegypti and Ae. albopictus mosquitoes for Zika virus HND and CAM. Graphs show proportion of blood-engorged mosquitoes infected, with disseminated infections, and...

Tables

• Table 1. Amino acid differences among Zika virus isolates used in study of species-specific Zika virus vector competence of Aedes mosquitoes
• Table 2. Zika virus vector competence of Aedes aegypti and Ae. albopictus mosquitoes at 21 days after infection

Cite This Article

DOI: 10.3201/eid2307.161633